← Leaderboards
Han Zhu
Stanford University
$3,310,233
Attributed
$3,310,233
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,310,233 · 5
By mechanism
R01$2,270,966 · 2
K08$713,673 · 1
R03$235,667 · 1
F32$89,927 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Edgar G. Engleman$35,389,843
- Edward S. Boyden$43,934,074
- Samuel Strober$36,157,957
- Kenan Christopher Garcia$35,612,900
- Nigam H Shah$12,105,021
Others in their field
Other Emerging Leaders on “Cardiac”
- Ionut Bebu · George Washington University$14,731,026
- Barbara Halina Braffett · George Washington University$14,731,026
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Romergryko Geocadin · University Of Michigan At Ann Arbor$9,719,654
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$9,716,114
- Nobuyuki Ishibashi · Children'S Research Institute$9,208,869
Research focus
CardiacCellsPathologicImmune Checkpoint InhibitorInflammationInflammatoryArrhythmiaMyocarditisT-LymphocyteHeartHeart FailureImmuneAntigensInsightPreventionClonal ExpansionMediatingMouse ModelPhenotypeMonoclonal AntibodiesBloodLifeCancer PatientMalignant Neoplasms
Grant awards (12)
A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 Blockade$773,843
R01 · FY2025 · HL · contact PI
Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping$745,169
R01 · FY2025 · HL · contact PI
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis$166,320
K08 · FY2025 · HL · contact PI
CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy Myocarditis$117,863
R03 · FY2025 · HL · contact PI
Investigating CXCR3 Blockade as Precision Therapy for Cardiac Sarcoidosis using Single-Cell Multi-omics and TCR Phenotyping$751,954
R01 · FY2024 · HL · contact PI
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis$166,320
K08 · FY2024 · HL · contact PI
CXCL9/10 Macrophage Induced CXCR3+ T-cell Recruitment to the Heart Contributes to Immunotherapy Myocarditis$117,804
R03 · FY2024 · HL · contact PI
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis$166,320
K08 · FY2023 · HL · contact PI
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis$48,393
K08 · FY2023 · HL · contact PI
Identification of Causal T-Cell Mechanisms in Immune Checkpoint Inhibitor Induced Myocarditis$166,320
K08 · FY2022 · HL · contact PI
Identification of Causal Antigens in Immune Checkpoint Inhibitor-Induced Myocarditis$17,697
F32 · FY2020 · HL · contact PI
Identification of Causal Antigens in Immune Checkpoint Inhibitor-Induced Myocarditis$72,230
F32 · FY2019 · HL · contact PI